The Safety and Efficacy of YTS109 Cell Injection for Relapsed/Refractory Autoimmune Hemolytic Anemia Patients After Receiving Three or More Lines of Therapy.
Latest Information Update: 17 Jan 2025
Price :
$35 *
At a glance
- Drugs YTS 109 (Primary)
- Indications Autoimmune haemolytic anaemia
- Focus Adverse reactions; Therapeutic Use
- 17 Jan 2025 New trial record